Studies related to Quality of Life and Ashwagandha

Efficacy Of Ashwagandha (Withania Somnifera [L.] Dunal) In Improving Cardiorespiratory Endurance In Healthy Athletic Adults

Effect Increase
Values WHO-QOL. All statistically significant. Physical: Placebo: before 58.88 (15.12), after 56.58 (10.82). Ashwagandha: before 62.88 (12.31), after 72.16 (13/64). Psychological. Placebo: before 60.71 (21.85), after 63.17 (14.12). Ashwagandha before 63.28 (11.64), after 75.72 (12.78). Social relationships. Placebo: before 57.79 (23.21), after 63.12 (18.13). Ashwagandha: before 60 (21.94), after 72.96 (17.11). Environmental. Placebo: before58.79 (16.97), after 60.17 (13.21). Ashwagandha: before 65.52 (12.37), after 71.88 (12.44).
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 50
Gender Both Genders
Age Range 18-29, 30-44
Body Types Average
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 50 healthy, young, active participants were allocated equally to take either 600 mg of ashwagandha (standardized 5% withanolides) or placebo daily for 12 weeks.

Compared with the placebo group, the ashwagandha group saw a statistically significant increase in VO2max as evaluated by 20-m shuttle test after 12 weeks. There were also statistically significant improvements in quality of life as measured by WHO-QOL for physical health, psychological health, social relationships, environmental factors.